Trial Profile
Phase I Trial of huA33 Plus 5-fluorouracil (5-FU), Leucovorin and Oxaliplatin in Patients With Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Jul 2021
Price :
$35
*
At a glance
- Drugs Monoclonal antibody A33 (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions
- 02 Mar 2009 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Actual patient number (20) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.